Oncoinvent ASA

OL:KLDVK USA Farm Products
Market Cap
$59.07 Million
Nkr673.07 Million NOK
Market Cap Rank
#28322 Global
#9446 in USA
Share Price
Nkr4.00
Change (1 day)
-6.98%
52-Week Range
Nkr4.00 - Nkr11.70
All Time High
Nkr11.70
About

Kaldvik AS engages in the salmon farming business in Iceland. It also operates smolt stations. The company was incorporated in 2020 and is headquartered in Eskifjörður, Iceland. Kaldvik AS was formerly known as Ice Fish Farm AS and changed its name to Kaldvik AS in August 2024. Kaldvik AS operates as a subsidiary of Austur Holding As.

Oncoinvent ASA (KLDVK) - Net Assets

Latest net assets as of December 2025: Nkr277.49 Million NOK

Based on the latest financial reports, Oncoinvent ASA (KLDVK) has net assets worth Nkr277.49 Million NOK as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr507.79 Million) and total liabilities (Nkr230.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Nkr277.49 Million
% of Total Assets 54.65%
Annual Growth Rate 25.38%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 31.46

Oncoinvent ASA - Net Assets Trend (2021–2025)

This chart illustrates how Oncoinvent ASA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Oncoinvent ASA (2021–2025)

The table below shows the annual net assets of Oncoinvent ASA from 2021 to 2025.

Year Net Assets Change
2025-12-31 Nkr277.49 Million +3.63%
2024-12-31 Nkr267.76 Million -5.62%
2023-12-31 Nkr283.70 Million +47.75%
2022-12-31 Nkr192.02 Million +71.03%
2021-12-31 Nkr112.27 Million --

Equity Component Analysis

This analysis shows how different components contribute to Oncoinvent ASA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components Nkr277.49 Million 100.00%
Total Equity Nkr277.49 Million 100.00%

Oncoinvent ASA Competitors by Market Cap

The table below lists competitors of Oncoinvent ASA ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Oncoinvent ASA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 267,760,000 to 277,488,000, a change of 9,728,000 (3.6%).
  • Net loss of 48,103,000 reduced equity.
  • New share issuances of 46,628,000 increased equity.
  • Other factors increased equity by 11,203,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Nkr-48.10 Million -17.34%
Share Issuances Nkr46.63 Million +16.8%
Other Changes Nkr11.20 Million +4.04%
Total Change Nkr- 3.63%

Book Value vs Market Value Analysis

This analysis compares Oncoinvent ASA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.43x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 1.95x to 2.43x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 Nkr2.05 Nkr4.00 x
2022-12-31 Nkr2.10 Nkr4.00 x
2023-12-31 Nkr2.32 Nkr4.00 x
2024-12-31 Nkr2.19 Nkr4.00 x
2025-12-31 Nkr1.65 Nkr4.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Oncoinvent ASA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -17.34%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -42.85%
  • • Asset Turnover: 0.22x
  • • Equity Multiplier: 1.83x
  • Recent ROE (-17.34%) is below the historical average (-5.52%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 1.78% 6.18% 0.19x 1.53x Nkr-9.23 Million
2022 -2.62% -8.89% 0.18x 1.62x Nkr-24.24 Million
2023 2.01% 19.18% 0.07x 1.51x Nkr-22.67 Million
2024 -11.43% -29.96% 0.21x 1.80x Nkr-57.39 Million
2025 -17.34% -42.85% 0.22x 1.83x Nkr-75.85 Million

Industry Comparison

This section compares Oncoinvent ASA's net assets metrics with peer companies in the Farm Products industry.

Industry Context

  • Industry: Farm Products
  • Average net assets among peers: $1,138,415,277
  • Average return on equity (ROE) among peers: -57.38%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Oncoinvent ASA (KLDVK) Nkr277.49 Million 1.78% 0.83x $10.48 Million
African Agriculture Holdings Inc (AAGRW) $-3.75 Million 0.00% 0.00x $107.62K
Atlantic Sapphire ASA (AASZF) $81.31 Million -8.12% 0.12x $8.52 Million
Australian Agricultural Company Limited (AAYYY) $671.99 Million 1.57% 0.73x $654.00 Million
Archer-Daniels-Midland Company (ADM) $8.53 Billion 12.24% 1.27x $33.40 Billion
Anglo-Eastern Plantations Plc (AEPLF) $572.98 Million 15.52% 0.10x $166.40 Million
Forafric Global PLC Ordinary Shares (AFRI) $5.32 Million -457.58% 45.29x $31.15 Million
Adecoagro SA (AGRO) $645.13 Million 1.55% 1.49x $272.09 Million
Agroz Inc. Ordinary Shares (AGRZ) $163.20K -177.61% 22.30x $4.61 Million
Alico Inc (ALCO) $115.49 Million 4.08% 1.37x $221.07 Million
Astral Foods Limited (ALFDF) $764.83 Million 34.55% 1.40x $170.88 Million